Furthermore, our studies revealed that the EGFR, MAPK3, MTOR, and PIK3R1 genes are effective and potential therapeutic agents for lowering the incidence of liver cancer and potentially exhibiting therapeutic effects on liver cancer. This evidence concerns the gene MAPK3 and liver cancer.